Scarica il programma

(1)

C M E P R OV I D E R A N D O R G A N I Z I N G AG E N CY

Events Congress&Communication Via Mantegna 1, 60019 Senigallia, Italy

Tel. +39 071 7930220 Fax. +39 071 7938406 www.events-communication.com segreteria3@events-communication.com

C O C K T A I L W I T H S C I E N C E

T H E B E ST O F T H E Y E A R I N LU N G CA N C E R

V I R T U A L C O N F E R E N C E S E PT E M B E R 7

^{T H}

- 8

^{T H}

2 0 2 0 – I TA LY

w w w. l u n g c a n c e r- m i l a n . c o m

PAT R O N AG E S

U N D E R T H E AU S P I C E S O F

V I RT UA L CO N F E R E N C E

The Event will be held as a video conference on our online platform.

The organizing secretariat will email the credentials for access.

R E G I ST R AT I O N

Registration online is free of charge:

www.lungcancer-milan.com

C . M . E

.

4,2 C.M.E. credits for medical doctors (all disciplines), biologists, pharmacists, nurses, health care assistants, medical laboratory technicians,medical radiology technicians. In order to receive credits, participants must:

1. Attend at least 90% of the accredited CME sessions

2. Complete online the CME test and the evaluation forms. CME certificate will be sent by email at the end of the validation S U P P O RT E D B Y

U N CO N D I T I O N A L E D U CAT I O N S P O N S O R S H I P F R O M

(2)

S C I E N T I F I C P R O G R A M FAC U LTY D A Y 1

S E P T E M B E R 7

^{T H}

17.00 Welcome and Introductions Marina Chiara Garassino

SESSION I

ONCOGENE ADDICTED

Chairs: A. Prelaj, C. Proto

17.10 Current treatment algorithms for EGFR-mutated patients Shirish Gadgeel

17.30 Current treatment algorithms for ALK+ and ROS1+ patients Pilar Garrido

17.50 Targeted therapies beyond EGFR, ALK and ROS1 Enriqueta Felip

18.10 The role of liquid biopsy in detecting and monitoring tumors with driver mutations Christian Rolfo

18.30 Round Table and Cocktail show

SPECIAL LECTURE

Chairs: M. C. Garassino, N. Zilembo 18.50 Patient empowerment and

shared decision making in NSCLC

Gabriella Pravettoni

SESSION II

NON ONCOGENE ADDICTED

Chairs: R. Ferrara, G. Lo Russo 19.10 I-O monotherapy

Martin Reck

19.30 Combo I-O/Chemo Marina Chiara Garassino 19.50 Combo I-O/I-O

Luis Paz-Ares

20.10 The future of I-O in advanced NSCLC

Filippo De Marinis 20.30 Biomarkers for I-O

Keith Kerr 20.50 Round Table

D A Y 2

S E P T E M B E R 8

^{T H}

17.00 Welcome and Introductions Marina Chiara Garassino

SESSION III

EARLY DISEASE

Chairs: M. P. Colombo, D. Signorelli 17.10 New neoadjuvant

perspectives in NSCLC David Carbone

17.30 Is there a role for Target therapies in early stages NSCLC?

YES Roy Herbst NO Benjamin Besse

18.10 Biomarkers for early detection of lung cancer?

Role of ctDNA Lecia Sequist Role of miRNA Gabriella Sozzi 18.50 Round Table and

Cocktail show

SPECIAL LECTURE

Chairs: M. C. Garassino, N. Zilembo 19.10 COVID-19 and thoracic cancer

Leora Horn

19.30 Conclusions and remarks

BESSE BENJAMIN

Institut Gustave Roussy, Villejuif FR CARBONE DAVID

The Ohio State University Comprehensive Cancer Center, Columbus, OH USA COLOMBO MARIO PAOLO

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano IT

DE MARINIS FILIPPO

Istituto Europeo di Oncologia, Milano IT FELIP ENRIQUETA

Vall d'Hebron Institute of Oncology and Autonomous University of Barcelona, Barcelona ES

FERRARA ROBERTO

GADGEEL SHIRISH

University of Michigan, Ann Arbor, MI USA GARASSINO MARINA CHIARA Fondazione IRCCS Istituto Nazionale dei Tumori, Milano IT

GARRIDO PILAR

University Hospital Ramón y Cajal and Universidad de Alcalá, Madrid ES HERBST ROY

Yale Cancer Center, New Heaven, CT USA HORN LEORA

Vanderbilt Ingram Cancer Center and Vanderbilt University Medical Center, Nashville , TN USA KERR KEITH

Aberdeen University Medical School and Aberdeen Royal Infirmary Foresthill, Aberdeen UK

LO RUSSO GIUSEPPE

PAZ-ARES LUIS

University Hospital 12 De Octubre, Madrid ES PRAVETTONI GABRIELLA

Istituto Europeo di Oncologia, Milano IT PRELAJ ARSELA

PROTO CLAUDIA

RECK MARTIN

LungenClinic Grosshansdorf, Großhansdorf DE ROLFO CHRISTIAN

University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, MD USA

SEQUIST LECIA,

Harvard Medical School and Massachusetts General Hospital,Boston, MA, USA

SIGNORELLI DIEGO

SOZZI GABRIELLA

ZILEMBO NICOLETTA

The official language for the conference

is English.

P R E S I D E N T Marina Chiara Garassino

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano IT

"Let’s break the ice in lung cancer"